New study tests PRP against standard creams for chronic vulvar condition
NCT ID NCT07240389
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares three treatments for vulvar lichen sclerosus, a chronic skin condition causing itching and pain. 45 women aged 30-80 will receive either a steroid cream, an immune-modulating cream, or platelet-rich plasma (PRP) injections. The goal is to see which approach best improves symptoms and quality of life over 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVAR LICHEN SCLEROSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Klinika Ginekologii i Ginekologii Onkologicznej, Szpital Uniwersytecki w Krakowie
Krakow, Małopolska, 31-261, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Laser zaps away lichen sclerosus symptoms in new trial
- Laser treatment could offer new hope for chronic skin condition
- Can a daily drink ease vaginal dryness in lichen sclerosus?
- New combo treatment tested for painful skin condition
- Could a common arthritis drug ease a devastating skin condition?
- Laser may offer new hope for women with chronic vulvar condition